Topstone Research, Toronto, Canada   Report issue

For profit Phase 2
Founded: Toronto Canada (2012)
Status: Acquired by Veristat, Inc. (2018)

Organization Overview

First Clinical Trial
2016
NCT02768805
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Topstone Clinical Research

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Infections (Phase 2)

Influenza, Human (Phase 2)

Respiratory Tract Diseases (Phase 2)

Respiratory Tract Infections (Phase 2)

RNA Virus Infections (Phase 2)

Stomach Ulcer (Phase 2)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 5